MINNEAPOLIS, June 6, 2017 /PRNewswire/ -- HLT, Inc. today announced the first U.S. patient implants in an early feasibility clinical study to assess the safety and performance outcomes of the Meridian ...
RADIANT clinical studytoevaluate safety and performance outcomes of HLT's Meridian ® Valve and Pathfinder ® II Delivery System for severe aortic stenosis MINNEAPOLIS, April 4, 2017 /PRNewswire/ -- HLT ...
RADIANT clinical study evaluating safety and performance outcomes of HLT's Meridian® Valve and Pathfinder® II Delivery System for severe aortic stenosis MINNEAPOLIS, June 6, 2017 /PRNewswire/ --HLT, ...
RADIANT clinical study to evaluate safety and performance outcomes of HLT's Meridian ® Valve and Pathfinder ® II Delivery System for severe aortic stenosis MINNEAPOLIS, April 4, 2017 /PRNewswire/ -- ...
RADIANT clinical study evaluating safety and performance outcomes of HLT's Meridian® Valve and Pathfinder® II Delivery System for severe aortic stenosis MINNEAPOLIS, June 6, 2017 /PRNewswire/ -- HLT, ...